Amnestix

Amnestix is a San Diego-based biotechnology company focused on the discovery and development of small molecule therapeutics for neurodegenerative and psychiatric disorders. The company was co-founded by prominent neuroscientists Dr. Roberto Malinow and Dr. Steven Wagner from the University of California, San Diego, leveraging their pioneering research into synaptic plasticity and memory formation. Amnestix's primary focus is on Alzheimer's disease, where it aims to develop drugs that can restore synaptic function and improve cognitive outcomes. Additionally, the company explores applications for its technology in treating conditions like post-traumatic stress disorder (PTSD) by targeting the molecular mechanisms of memory retention. Amnestix operates primarily in the pre-clinical stage, utilizing proprietary insights into molecular signaling pathways in the brain to identify novel drug candidates.